AGFA-GEVAERT NV (AGFB.BR) Fundamental Analysis & Valuation

EBR:AGFB • BE0003755692

Current stock price

0.475 EUR
0 (-0.11%)
Last:

This AGFB.BR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. AGFB.BR Profitability Analysis

1.1 Basic Checks

  • In the past year AGFB has reported negative net income.
  • In the past year AGFB had a positive cash flow from operations.
  • In the past 5 years AGFB always reported negative net income.
  • AGFB had negative operating cash flow in 4 of the past 5 years.
AGFB.BR Yearly Net Income VS EBIT VS OCF VS FCFAGFB.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M 600M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -5.64%, AGFB is doing worse than 66.67% of the companies in the same industry.
  • AGFB has a Return On Equity of -28.35%. This is in the lower half of the industry: AGFB underperforms 66.67% of its industry peers.
Industry RankSector Rank
ROA -5.64%
ROE -28.35%
ROIC N/A
ROA(3y)-6.57%
ROA(5y)-6.62%
ROE(3y)-27.45%
ROE(5y)-25.51%
ROIC(3y)N/A
ROIC(5y)N/A
AGFB.BR Yearly ROA, ROE, ROICAGFB.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 100

1.3 Margins

  • AGFB has a worse Gross Margin (30.11%) than 75.00% of its industry peers.
  • AGFB's Gross Margin has been stable in the last couple of years.
  • The Profit Margin and Operating Margin are not available for AGFB so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 30.11%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.08%
GM growth 5Y0.88%
AGFB.BR Yearly Profit, Operating, Gross MarginsAGFB.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. AGFB.BR Health Analysis

2.1 Basic Checks

  • AGFB does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for AGFB remains at a similar level compared to 1 year ago.
  • Compared to 5 years ago, AGFB has less shares outstanding
  • The debt/assets ratio for AGFB is higher compared to a year ago.
AGFB.BR Yearly Shares OutstandingAGFB.BR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
AGFB.BR Yearly Total Debt VS Total AssetsAGFB.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.2 Solvency

  • AGFB has an Altman-Z score of 2.19. This is not the best score and indicates that AGFB is in the grey zone with still only limited risk for bankruptcy at the moment.
  • AGFB has a Altman-Z score of 2.19. This is comparable to the rest of the industry: AGFB outperforms 58.33% of its industry peers.
  • The Debt to FCF ratio of AGFB is 5.83, which is a neutral value as it means it would take AGFB, 5.83 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of AGFB (5.83) is comparable to the rest of the industry.
  • AGFB has a Debt/Equity ratio of 0.60. This is a neutral value indicating AGFB is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.60, AGFB is in line with its industry, outperforming 50.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF 5.83
Altman-Z 2.19
ROIC/WACCN/A
WACC7.08%
AGFB.BR Yearly LT Debt VS Equity VS FCFAGFB.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

2.3 Liquidity

  • AGFB has a Current Ratio of 1.78. This is a normal value and indicates that AGFB is financially healthy and should not expect problems in meeting its short term obligations.
  • AGFB has a better Current ratio (1.78) than 66.67% of its industry peers.
  • AGFB has a Quick Ratio of 1.15. This is a normal value and indicates that AGFB is financially healthy and should not expect problems in meeting its short term obligations.
  • AGFB has a Quick ratio of 1.15. This is comparable to the rest of the industry: AGFB outperforms 41.67% of its industry peers.
Industry RankSector Rank
Current Ratio 1.78
Quick Ratio 1.15
AGFB.BR Yearly Current Assets VS Current LiabilitesAGFB.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. AGFB.BR Growth Analysis

3.1 Past

  • AGFB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 16.59%, which is quite good.
  • Looking at the last year, AGFB shows a decrease in Revenue. The Revenue has decreased by -4.57% in the last year.
  • AGFB shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -8.67% yearly.
EPS 1Y (TTM)16.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-5.26%
Revenue 1Y (TTM)-4.57%
Revenue growth 3Y-1.75%
Revenue growth 5Y-8.67%
Sales Q2Q%-5.85%

3.2 Future

  • Based on estimates for the next years, AGFB will show a very strong growth in Earnings Per Share. The EPS will grow by 47.80% on average per year.
  • The Revenue is expected to grow by 2.10% on average over the next years.
EPS Next Y155.56%
EPS Next 2Y85.59%
EPS Next 3Y47.8%
EPS Next 5YN/A
Revenue Next Year0.54%
Revenue Next 2Y1.33%
Revenue Next 3Y2.1%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
AGFB.BR Yearly Revenue VS EstimatesAGFB.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B 2B 2.5B
AGFB.BR Yearly EPS VS EstimatesAGFB.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.2 -0.2 0.4 -0.4 0.6

More info and screens

Find the best growth stocksShow best growing peers

6

4. AGFB.BR Valuation Analysis

4.1 Price/Earnings Ratio

  • AGFB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • A Price/Forward Earnings ratio of 9.31 indicates a reasonable valuation of AGFB.
  • Based on the Price/Forward Earnings ratio, AGFB is valued cheaply inside the industry as 91.67% of the companies are valued more expensively.
  • When comparing the Price/Forward Earnings ratio of AGFB to the average of the S&P500 Index (22.42), we can say AGFB is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 9.31
AGFB.BR Price Earnings VS Forward Price EarningsAGFB.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AGFB is on the same level as its industry peers.
  • 91.67% of the companies in the same industry are more expensive than AGFB, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 2.54
EV/EBITDA 151.62
AGFB.BR Per share dataAGFB.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as AGFB's earnings are expected to grow with 47.80% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y85.59%
EPS Next 3Y47.8%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. AGFB.BR Dividend Analysis

5.1 Amount

  • No dividends for AGFB!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

AGFB.BR Fundamentals: All Metrics, Ratios and Statistics

AGFA-GEVAERT NV

EBR:AGFB (3/23/2026, 3:36:52 PM)

0.475

0 (-0.11%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)03-11
Earnings (Next)05-12
Inst Owners47.94%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap73.54M
Revenue(TTM)1.09B
Net Income(TTM)-72.00M
Analysts43.64
Price Target0.88 (85.26%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-8.65%
Min Revenue beat(2)-10.18%
Max Revenue beat(2)-7.11%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 9.31
P/S 0.07
P/FCF 2.54
P/OCF 1.17
P/B 0.29
P/tB 4.6
EV/EBITDA 151.62
EPS(TTM)-0.48
EYN/A
EPS(NY)0.05
Fwd EY10.74%
FCF(TTM)0.19
FCFY39.43%
OCF(TTM)0.41
OCFY85.67%
SpS7.01
BVpS1.64
TBVpS0.1
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -5.64%
ROE -28.35%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 30.11%
FCFM 2.67%
ROA(3y)-6.57%
ROA(5y)-6.62%
ROE(3y)-27.45%
ROE(5y)-25.51%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.08%
GM growth 5Y0.88%
F-Score4
Asset Turnover0.85
Health
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF 5.83
Debt/EBITDA 152
Cap/Depr 94.44%
Cap/Sales 3.13%
Interest Coverage N/A
Cash Conversion 6300%
Profit Quality N/A
Current Ratio 1.78
Quick Ratio 1.15
Altman-Z 2.19
F-Score4
WACC7.08%
ROIC/WACCN/A
Cap/Depr(3y)92.38%
Cap/Depr(5y)74.29%
Cap/Sales(3y)3.35%
Cap/Sales(5y)2.88%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-5.26%
EPS Next Y155.56%
EPS Next 2Y85.59%
EPS Next 3Y47.8%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.57%
Revenue growth 3Y-1.75%
Revenue growth 5Y-8.67%
Sales Q2Q%-5.85%
Revenue Next Year0.54%
Revenue Next 2Y1.33%
Revenue Next 3Y2.1%
Revenue Next 5YN/A
EBIT growth 1Y28.57%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year536.84%
EBIT Next 3Y113.87%
EBIT Next 5YN/A
FCF growth 1Y159.18%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1675%
OCF growth 3YN/A
OCF growth 5YN/A

AGFA-GEVAERT NV / AGFB.BR Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for AGFA-GEVAERT NV?

ChartMill assigns a fundamental rating of 3 / 10 to AGFB.BR.


What is the valuation status for AGFB stock?

ChartMill assigns a valuation rating of 6 / 10 to AGFA-GEVAERT NV (AGFB.BR). This can be considered as Fairly Valued.


How profitable is AGFA-GEVAERT NV (AGFB.BR) stock?

AGFA-GEVAERT NV (AGFB.BR) has a profitability rating of 1 / 10.


Can you provide the expected EPS growth for AGFB stock?

The Earnings per Share (EPS) of AGFA-GEVAERT NV (AGFB.BR) is expected to grow by 155.56% in the next year.


Is the dividend of AGFA-GEVAERT NV sustainable?

The dividend rating of AGFA-GEVAERT NV (AGFB.BR) is 0 / 10 and the dividend payout ratio is 0%.